Your Article Summary
Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues
Neuropsychiatric Disease and Treatment, 07/02/09
Bobo WV et al. - While effective during acute-phase treatment, questions remain regarding the long-term efficacy and safety of FLX/OLZ relative to antidepressant monotherapy and other combination strategies. Efforts aimed at determining the placement of FLX/OLZ among the available options for addressing TRD are limited by lack of comparison and sequential treatment studies. Important aspects of study design and directions for future research are discussed.
Methods- In each study, the FLX/OLZ combination caused rapid reduction in Montgomery-Asberg Depression Rating scale scores, with two of the four studies showing significantly greater improvement than antidepressant monotherapy at study endpoint.
- Effects of the FLX/OLZ combination were strongest in cases where failure to respond to two antidepressants prior to randomization was established during the current depressive episode.
- The FLX/OLZ combination was well-tolerated; however, body weight gain and increases in prolactin were greater than that of the antidepressant monotherapy groups, and were comparable to that of OLZ monotherapy.
Today in Mood Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Evaluation of screening instruments for depression and anxiety in breast cancer survivors
Breast Cancer Research and Treatment, 12/10/09
Clinical Effectiveness of Individual Cognitive Behavioral Therapy for Depressed Older People in Primary Care: A Randomized Controlled Trial
Archives of General Psychiatry, 12/10/09
Sex Differences in the Prevalence of Post-Stroke Depression: A Systematic Review
Psychosomatics, 12/10/09
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Blood pressure changes during clozapine or olanzapine treatment in Korean schizophrenic patients
World Journal of Biological Psychiatry, 12/10/09
Role of Infection in the Pathogenesis of Alzheimers Disease: Implications for Treatment
CNS Drugs, 12/10/09
Update on the management of attention-deficit/hyperactivity disorder in children and adults: patient onsiderations and the role of lisdexamfetamine
Therapeutics and Clinical Risk Management, 12/10/09

See Latest Articles